Diamond Biotechnology Co., Ltd (TPEX:6815)

Diamond Biotechnology Revenue

In the year 2025, Diamond Biotechnology had annual revenue of 501.49M TWD, down -34.72%. Diamond Biotechnology had revenue of 317.60M in the half year ending June 30, 2025, with 7.19% growth.

• Revenue: 501.49M
• Revenue Growth: -34.72%
• P/S Ratio: 2.41
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	501.49M	-266.76M	-34.72%
Dec 31, 2024	768.25M	152.16M	24.70%
Dec 31, 2023	616.10M	181.25M	41.68%
Dec 31, 2022	434.84M	39.64M	10.03%
Dec 31, 2021	395.20M	88.81M	28.99%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 7, 2026

Data Sources Report a data error